| 000 | 01845 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517090328.0 | ||
| 264 | 0 | _c20170222 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a1879-1883 | ||
| 024 | 7 |
_a10.1016/j.amjsurg.2015.12.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBosch, Dirk J | |
| 245 | 0 | 0 |
_aLongitudinal analysis of cytokine expression during neoadjuvant chemoradiotherapy and subsequent surgery in esophageal cancer patients. _h[electronic resource] |
| 260 |
_bAmerican journal of surgery _cJul 2016 |
||
| 300 |
_a89-95 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xmortality |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xmortality |
| 650 | 0 | 4 |
_aChemoradiotherapy _xadverse effects |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCytokines _xblood |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xmortality |
| 650 | 0 | 4 |
_aEsophagectomy _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xadverse effects |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWang, Da | |
| 700 | 1 | _aNijsten, Maarten W N | |
| 700 | 1 | _aMul, Véronique E M | |
| 700 | 1 | _aHospers, Geke A P | |
| 700 | 1 | _aBurgerhof, Johannes G M | |
| 700 | 1 | _aStruys, Michel M R F | |
| 700 | 1 | _aPlukker, John Th M | |
| 773 | 0 |
_tAmerican journal of surgery _gvol. 212 _gno. 1 _gp. 89-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjsurg.2015.12.021 _zAvailable from publisher's website |
| 999 |
_c25885021 _d25885021 |
||